跳转至内容
Merck
CN
  • Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.

Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.

Antimicrobial agents and chemotherapy (2009-03-11)
Yang Liu, Xinyu Ye, Hong Zhang, Xiaogang Xu, Wanhua Li, Demei Zhu, Minggui Wang
摘要

Fifty-three Mycoplasma pneumoniae strains were isolated from pediatric patients in Shanghai, China, from October 2005 to February 2008. Of 53 clinical isolates, 44 (83%) were resistant to erythromycin (MICs of >128 microg/ml for all 44 strains), azithromycin, and clarithromycin. All macrolide-resistant M. pneumoniae strains harbored an A-to-G transition mutation at position 2063 in 23S rRNA genes. Forty-five (85%) clinical isolates were classified into the P1 gene restriction fragment length polymorphism type I, and six (11%) were type II.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
红霉素, BioReagent, suitable for cell culture
Sigma-Aldrich
环丙沙星, ≥98% (HPLC)
Sigma-Aldrich
四环素, 98.0-102.0% (HPLC)
Sigma-Aldrich
左氧氟沙星, 98.0-102.0% anhydrous basis (HPLC)
Sigma-Aldrich
红霉素, potency: ≥850 μg per mg
Sigma-Aldrich
Josamycin, ≥90% (HPLC)
Supelco
环丙沙星, VETRANAL®, analytical standard
Sigma-Aldrich
红霉素, meets USP testing specifications
Sigma-Aldrich
红霉素, tested according to Ph. Eur.